» Articles » PMID: 31709079

Crystal Structure, DFT Calculation, Hirshfeld Surface Analysis and Energy Framework Study of 6-bromo-2-(4-bromo-phen-yl)imidazo[1,2-]pyridine

Overview
Date 2019 Nov 12
PMID 31709079
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

The title imidazo[1,2-] pyridine derivative, CHBrN, was synthesized a single-step reaction method. The title mol-ecule is planar, showing a dihedral angle of 0.62 (17)° between the phenyl and the imidazo[1,2-] pyridine rings. An intra-molecular C-H⋯N hydrogen bond with an (5) ring motif is present. In the crystal, a short H⋯H contact links adjacent mol-ecules into inversion-related dimers. The dimers are linked in turn by weak C-H⋯π and slipped π-π stacking inter-actions, forming layers parallel to (110). The layers are connected into a three-dimensional network by short Br⋯H contacts. Two-dimensional fingerprint plots and three-dimensional Hirshfeld surface analysis of the inter-molecular contacts reveal that the most important contributions for the crystal packing are from H⋯Br/Br⋯H (26.1%), H⋯H (21.7%), H⋯C/C⋯H (21.3%) and C⋯C (6.5%) inter-actions. Energy framework calculations suggest that the contacts formed between mol-ecules are largely dispersive in nature. Analysis of HOMO-LUMO energies from a DFT calculation reveals the pure π character of the aromatic rings with the highest electron density on the phenyl ring, and σ character of the electron density on the Br atoms. The HOMO-LUMO gap was found to be 4.343 eV.

Citing Articles

Comprehensive analysis of crystal structure, spectroscopic properties, quantum chemical insights, and molecular docking studies of two pyrazolopyridine compounds: potential anticancer agents.

Polo-Cuadrado E, Lopez-Cuellar L, Acosta-Quiroga K, Rojas-Pena C, Brito I, Cisterna J RSC Adv. 2023; 13(43):30118-30128.

PMID: 37849708 PMC: 10578360. DOI: 10.1039/d3ra04874h.


Piperonal chalcone derivative incorporating the pyrazolo[3,4-]pyridine moiety; crystal structure, spectroscopic characterization and quantum chemical investigations.

Polo-Cuadrado E, Ferrer K, Osorio E, Brito I, Cisterna J, Espinoza L RSC Adv. 2023; 13(8):5197-5207.

PMID: 36777942 PMC: 9910059. DOI: 10.1039/d2ra08101f.


Crystal structure of 4-bromo--(propyl-carbamo-yl)benzene-sulfonamide.

Bookwala M, Patel S, Flaherty P, Wildfong P Acta Crystallogr E Crystallogr Commun. 2022; 78(Pt 5):485-489.

PMID: 35547791 PMC: 9069509. DOI: 10.1107/S2056989022003723.


Crystal structure and Hirshfeld surface analysis of 2,2,2-tri-fluoro-1-(7-methyl-imidazo[1,2-]pyridin-3-yl)ethan-1-one.

Guseinov F, Kobrakov K, Ugrak B, Atioglu Z, Akkurt M, Bhattarai A Acta Crystallogr E Crystallogr Commun. 2022; 78(Pt 1):12-17.

PMID: 35079415 PMC: 8739203. DOI: 10.1107/S2056989021012676.

References
1.
Vega D, Baggio R, Roca M, Tombari D . Aging-driven decomposition in zolpidem hemitartrate hemihydrate and the single-crystal structure of its decomposition products. J Pharm Sci. 2010; 100(4):1377-86. DOI: 10.1002/jps.22358. View

2.
Rupert K, Henry J, Dodd J, Wadsworth S, Cavender D, Olini G . Imidazopyrimidines, potent inhibitors of p38 MAP kinase. Bioorg Med Chem Lett. 2003; 13(3):347-50. DOI: 10.1016/s0960-894x(02)01020-x. View

3.
Rival Y, Grassy G, Michel G . Synthesis and antibacterial activity of some imidazo[1,2-a]pyrimidine derivatives. Chem Pharm Bull (Tokyo). 1992; 40(5):1170-6. DOI: 10.1248/cpb.40.1170. View

4.
Mutai T, Tomoda H, Ohkawa T, Yabe Y, Araki K . Switching of polymorph-dependent ESIPT luminescence of an imidazo[1,2-a]pyridine derivative. Angew Chem Int Ed Engl. 2008; 47(49):9522-4. DOI: 10.1002/anie.200803975. View

5.
Anaflous A, Albay H, Benchat N, El Bali B, Dusek M, Fejfarova K . 2-Phenyl-imidazo[1,2-a]pyridine-3-carbaldehyde. Acta Crystallogr Sect E Struct Rep Online. 2011; 64(Pt 5):o927. PMC: 2961188. DOI: 10.1107/S1600536808011306. View